{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "esgPopulated": false, "market": "dr_market", "longName": "Genflow Biosciences plc", "marketState": "REGULAR", "regularMarketPrice": 0.033, "messageBoardId": "finmb_1763803753", "exchange": "FRA", "shortName": "GENFLOW BIOSCIENCES PLC", "exchangeTimezoneShortName": "CEST", "exchangeTimezoneName": "Europe/Berlin", "regularMarketChangePercent": -2.9411824, "gmtOffSetMilliseconds": 7200000, "fiftyTwoWeekLowChange": 0.015999999, "fiftyTwoWeekLowChangePercent": 0.94117635, "fiftyTwoWeekRange": "0.017 - 0.078", "fiftyTwoWeekHighChange": -0.045, "fiftyTwoWeekHighChangePercent": -0.5769231, "fiftyTwoWeekLow": 0.017, "fiftyTwoWeekHigh": 0.078, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.0, "firstTradeDateMilliseconds": 1643785200000, "priceHint": 4, "regularMarketChange": -0.001000002, "regularMarketTime": 1683875702, "regularMarketDayHigh": 0.033, "regularMarketDayRange": "0.033 - 0.033", "regularMarketDayLow": 0.033, "regularMarketVolume": 50000, "regularMarketPreviousClose": 0.034, "bid": 0.033, "ask": 0.038, "fullExchangeName": "Frankfurt", "financialCurrency": "GBP", "regularMarketOpen": 0.033, "averageDailyVolume3Month": 847, "averageDailyVolume10Day": 0, "sharesOutstanding": 292507008, "bookValue": 0.01, "fiftyDayAverage": 0.02916, "fiftyDayAverageChange": 0.0038399994, "fiftyDayAverageChangePercent": 0.13168722, "twoHundredDayAverage": 0.02762, "twoHundredDayAverageChange": 0.005379999, "twoHundredDayAverageChangePercent": 0.19478634, "marketCap": 12357246, "priceToBook": 3.3, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "symbol": "WQ5.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "15 Ingestre Place", "address2": "Suite 1", "city": "London", "zip": "W1F 0DU", "country": "United Kingdom", "phone": "44 32 4774 95881", "website": "https://genflowbio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Genflow Biosciences plc operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing or halting the ageing process, and reducing the incidence of age-related diseases with increase in health span. Its lead compound is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-3001, a topical delivery of SIRT6 to the skin; and GF-4001, a non-human pipeline anti-aging for veterinary use. The company was incorporated in 2021 and is headquartered in London, the United Kingdom.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Dr. Eric Jean Leire M.D., MBA", "age": 64, "title": "Founder, CEO & Exec. Director", "yearBorn": 1958, "fiscalYear": 2021, "totalPay": {"raw": 186871, "fmt": "186.87k", "longFmt": "186,871"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Cedric  Szpirer", "title": "Head of CMC", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}